4//SEC Filing
Durenard Eugene 4
Accession 0001812942-25-000002
CIK 0001692415other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 5:29 PM ET
Size
7.9 KB
Accession
0001812942-25-000002
Insider Transaction Report
Form 4
Durenard Eugene
Director
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-11-23−57,499→ 170,834 totalExercise: $0.00→ Common Stock (228,333 underlying) - Award
Common Stock
2025-11-23+57,499→ 269,166 total
Footnotes (1)
- [F1]Included in 40,000 restricted stock units awarded to the Reporting Person on January 17, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on May 23, 2023. Included in 70,000 restricted stock units awarded to the Reporting Person on June 12, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2023. Included in 110,000 restricted stock units awarded to the Reporting Person on April 26, 2024, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2024. Included in 125,000 restricted stock units awarded to the Reporting Person on August 13, 2025, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2025.
Documents
Issuer
Co-Diagnostics, Inc.
CIK 0001692415
Entity typeother
Related Parties
1- filerCIK 0001812942
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 5:29 PM ET
- Size
- 7.9 KB